Chinese Biopharma Stocks Surge on U.S. Drug Licensing Outlook
Chinese biopharma stocks rallied in Hong Kong trading following reports that Washington is weighing rules to let American pharmaceutical companies continue licensing most drugs from mainland Chinese firms, diverging sharply from the tighter restrictions imposed on artificial intelligence and semiconductor sectors. Regulatory Outlook Boosts Hong Kong Biopharma Stocks Market response was swift after news emerged … Read more